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This paper reports the use of a quadrupole time-of-flight (Q-TOF) mass spectrometer fitted
with a matrix-assisted laser desorption/ionization (MALDI) ion source for the analysis of
neutral and acidic glycosphingolipids. All compounds gave strong [M  Na] ions with
2,5-dihydroxybenzoic acid as the matrix, with no loss of sensitivity with increasing mass as
was observed from the corresponding ions produced by electrospray. Neutral glycosphingo-
lipids showed negligible in-source fragmentation but sialylated compounds fragmented by
loss of sialic acid. However, these losses were not accompanied by unfocused post-source-
decay ions as observed with MALDI-reflectron-TOF instruments. The MS/MS spectra were
almost identical to those obtained by electrospray. Fragmentation of all compounds was
mainly by glycosidic cleavage to give ions, both with and without the ceramide moiety, which
defined the carbohydrate chain sequence. Weak ions which defined the sphingosine chain
length and abundant ions, produced by loss of the acyl chain, were present when this chain
contained a 2-hydroxy group. The technique was applied to the identification of ceramide–
trihexosides present in tissues from mice genetically modified to model one of the glycolipid
storage diseases (Fabry disease). (J Am Soc Mass Spectrom 2001, 12, 1220–1225) © 2001
American Society for Mass Spectrometry
Glycosphingolipids (GSLs) consist of a non-polarlipid (ceramide) portion that acts as a mem-brane anchor and a water-soluble carbohydrate
moiety, and are ubiquitous components of eukaryotic
plasma membranes [1]. They have many cellular func-
tions [2] such as cell–cell recognition, cell growth and
signal transduction. Structural analyses have been car-
ried out by mass spectrometry for many years and have
been the subject of several reviews (see, for example
[3–8]. Early work was performed using fast-atom bom-
bardment (FAB) ionization but more recently electros-
pray and MALDI ionization techniques have been suc-
cessfully used.
Analysis of GSLs by FAB mass spectrometry requires
a relatively large quantity of sample [5, 9]. By compar-
ison, MALDI mass spectrometry can produce signals
from much smaller amounts of material [10, 11] without
the need for derivatization. The resulting spectra con-
tain few, if any, fragment ions and thus, fragmentation
studies require additional stages of analysis. Fragmen-
tation from samples ionized by MALDI and recorded
with TOF mass analyzers is generally restricted to that
obtained by post-source decay (PSD) [10, 12], a tech-
nique that produces fragment ions with relatively poor
resolution. However, instruments are now available in
which MALDI has been interfaced with a tandem
quadrupole-TOF analyzer [13] and which have been
shown to provide excellent MS/MS data from proteins
[13–15] and carbohydrates [16]. This paper reports the
use of this type of instrument for the analysis of
glycosphingolipids.
Experimental
Materials
GSLs, all from bovine brain, except glucosylceramide
which was from human Gaucher’s spleen, were ob-
tained from Sigma, (Poole, Dorset, UK) and used as
supplied. All solvents were of analytical grade and
were purchased from Sigma; the MALDI matrices,
2,5-dihydroxybenzoic acid (DHB), 1,4-dihydroxynaph-
thoic acid, 1,3,5-trihydroxyacetophenone (THAP) and
2-(4'-hydroxyphenyl)azobenzoic acid (HABA) were
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from Aldrich Chemical Co. Ltd., (Poole, Dorset, UK).
Dextran sugars were obtained from Fluka Biochemika
(Poole, UK). GSLs from the liver of Fabry mice were
purified as described below. Silica 60 was purchased
from Merck, (Darmstadt, Germany) and conditioned
overnight at 80 °C before use.
Extraction of Glycosphingolipids from Fabry
Mouse Liver and Kidney
GSLs were extracted with a mixture of chloroform:
methanol (2:1, vol:vol, 2 ml) from 50 mg of tissue [17]
dispersed into 1 ml of water by shaking for 3 h. The
mixture was centrifuged at 3000 rpm for 10 min, the
supernatant was removed, and the process was re-
peated. Pooled supernatants were freeze-dried over-
night and purified by silicic acid chromatography.
Neutral GSLs were eluted with acetone:methanol (9:1
vol:vol, 9 ml) [18] and dried (nitrogen stream).
MALDI Mass Spectrometry
A mixture of sample (1 l, 100 pmol) and matrix (1 l of
a saturated solution of 2,5-DHB in acetonitrile) were
crystallized on the MALDI target. Positive ion reflec-
tron MALDI and PSD spectra were obtained with a
Micromass TOFSpec 2E mass spectrometer equipped
with delayed extraction (Micromass UK, Ltd., Wythen-
shawe, Manchester). The instrument was operated as
follows: accelerating voltage, 20 kV; pulse voltage, 3200
V; laser repetition rate of 10 Hz and calibrated exter-
nally with hydrolyzed dextran sugars.
Electrospray Mass Spectrometry
Nanoflow electrospray mass spectra were obtained
with a Micromass Q-TOF mass spectrometer (Z-spray
ion source). Samples (10 l, 100 pmol), in chloroform:
methanol (2:1, vol/vol), were infused at 400 nL/min.
Operating conditions were: needle voltage, 3kV; ion
source temperature, 100 °C; collision gas, argon at 20
psi, spectrum acquisition time, 1 s.
MALDI-Q-TOF Mass Spectrometry
The mass spectrometer was a Micromass Q-TOF instru-
ment fitted with an experimental MALDI ion source as
described earlier [16]. Air was introduced to give a
pressure of 0.1 mbar to provide collisional cooling of the
ion beam to thermal levels in the hexapole ion guide
[13]. Argon was used as the collision gas and the
voltage on the collision cell was varied by about 10 V
around the mean value (usually about 85 V). The mass
window for precursor ion selection was about four
mass units.
Results and Discussion
Neutral Glycosphingolipids
Figure 1 shows a comparison of the MS spectra of a
mixture of neutral GSLs (approximately 100 pmoles of
each was sampled, of which about 10% was used)
recorded by MALDI using DHB as a matrix on the
MALDI-Q-TOF instrument (Figure 1a), by electrospray
(Figure 1b), and with a conventional MALDI-TOF in-
strument (Figure 1c). The MALDI-Q-TOF spectrum
(Figure 1a) was similar to the MALDI spectrum re-
corded directly with the reflectron-TOF instrument
(Figure 1c); neither spectrum showed the loss of sensi-
tivity with increasing mass that was observed with the
electrospray instrument (Figure 1b), an observation
similar to that made earlier with N-linked carbohy-
drates [16]. No significant in-source fragmentation oc-
curred during MALDI ionization. However, the higher
laser power used by the MALDI Q-TOF instrument
produced a slightly higher background than in the
reflectron-TOF spectrum.
Acidic (Sialo-) Glycosphingolipids
Unlike spectra of neutral GSLs, the spectrum of the
sialylated ganglioside GM1 recorded with the MALDI-
TOF instrument (data not shown) showed extensive
fragmentation by loss of sialic acid [10, 11, 19] leading to
both focused (m/z 1277.7 and 1305.6) in-source frag-
ments and unfocused, post-source or metastable ions
(m/z 1317.2 and 1345.2) [20]. The positive ion MALDI-
Q-TOF spectrum of this compound, on the other hand,
although showing significant in-source fragmentation
contained no metastable ions. Less fragmentation was
observed with neutral matrices, such as THAP, or by
using electrospray ionization, the latter observation
paralleling those made by Penn et al. [21].
Additional fragmentation of acidic glycolipids was
observed with the MALDI-Q-TOF instrument to give
the ions at m/z 940.7 and 912.7 (20% relative abundance)
by loss of Gal13 3GalNAc from m/z 1305.9 and 1277.9
respectively (Y2 cleavage) (Domon and Costello [22]
nomenclature), and ions at m/z 1552.9 and 1524.9 (20%)
by loss of carbon dioxide [10]. Two weak (10%) ions at
m/z 1441.9 and 1413.8. appeared to be adducts with a
dehydration product (136 mass units) of the matrix as
they were absent from the spectra recorded from 1,4-
dihydroxynaphthoic acid (an analogue of DHB), HABA
or THAP, and from the corresponding MS/MS spectra.
MS/MS Spectra of Neutral Glycosphingolipids
The MS/MS spectra of neutral GSLs, such as those from
GA2 obtained on the MALDI-Q-TOF instrument, (Fig-
ure 2a) were almost identical to those obtained on the
electrospray Q-TOF instrument (Figure 2b) demonstrat-
ing effective decoupling of the ion source from the
analytical stage of the instrument. The MALDI-PSD
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spectrum recorded with a reflectron-TOF instrument,
on the other hand (Figure 2c), although showing the
same series of Y ions, as reported by others [19], was
less informative and the fragment ions were poorly
focused.
The major ions seen in both MALDI and electrospray
MS/MS spectra were due to Y-type glycosidic cleav-
ages of the glycan chain (m/z 912.7, 750.6, 588.5 in Figure
2) involving loss of a hydroxylic hydrogen atom, as
shown by deuterium labeling [23]. This is in line with
earlier studies on the cleavages of complex sugars [24].
Other fragment ions are annotated in Figure 2. The
prominent ions formed by loss of the entire carbohy-
drate moiety together with H2CO reported by Hsu and
Turk [23] in the spectra of lithium adducted glycolipids,
and which we have also found in electrospray spectra,
were absent. Lithium has previously been reported to
catalyze more fragmentation from carbohydrates than
sodium [25].
The ion at m/z 264, derived from the sphingosine
chain [23, 26–29] and defining its length as C-18, was
weak but quite distinct in the MALDI Q-TOF spectrum
as shown by the inset to Figure 2. Its relative abundance
fell as the number of sugar residues increased but was
generally more abundant in these MALDI spectra than
in the ones recorded with the electrospray Q-TOF
instrument. The ion is interesting in that it is a proton-
ated species derived from a sodiated molecular ion.
Several structures have been proposed for this ion; for
example, Olling et al. [28] favor a structure containing a
carbonium ion whereas Hsu and Turk [23] have pro-
posed a cyclic ethyleneiminium ion.
GSLs containing 2-hydroxy fatty acyl groups, such as
that shown for the LacCer in Figure 3 (2-hydroxy-24:0
acyl), were characterized by an abundant ion produced
by loss of the hydroxy-acyl group (m/z 646.4) [23,
28–30]. A further loss of galactose was observed from
this ion to give m/z 484.3 and a weaker ion at m/z 674.3
was formed by cleavage between the acyl carbonyl
group and the C2-carbon atom. In other respects, the
fragmentation was similar to that of GSLs containing
unsubstituted fatty acids.
MS/MS Spectra of Acidic Glycosphingolipids
MS/MS spectra of acidic GSLs were similar to those
of the neutral compounds with the major fragments
being due to loss of the sialic acid moieties. Where the
sialic acids formed sodium salts, loss of sialic acid
loss was suppressed, presumably because of the
absence of the labile acidic proton that was presumed
to migrate during the Y cleavage. Where sialic acids
were chained, as in the ganglioside GD3 (Neu5Ac23 8
Neu5Ac23 3Gal13 4Glc13 Cer), the presence of the
Neu5Ac23 8Neu5Ac group in this molecule was re-
flected by the B ions at m/z 314.1 and 605.2 correspond-
ing to the sodium adducts of fragments containing one
and two sialic acids, respectively. Where a single sialic
Figure 1. Mass spectra of a mixture of neutral glycosphingolipids recorded (a) by MALDI with the
MALDI Q-TOF mass spectrometer, (b) by electrospray with the Q-TOF mass spectrometer, and (c) by
MALDI with a reflectron-TOF mass spectrometer. R is used to represent heterogeneity in the acyl
chain. Acyl groups contain from 16 to 24 carbon atoms.
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Figure 2. MALDI MS/MS spectra of the neutral glycosphingolipid GA2 (C18 sphingosine and acyl
groups) recorded with (a) the MALDI Q-TOF mass spectrometer and (b) the reflectron-TOF mass
spectrometer. (c) Shows the corresponding PSD spectrum. The inset to spectrum (a) shows a
magnification of the region containing the ion at m/z 264.1.
Figure 3. MALDI MS/MS spectrum of lactosylceramide containing a 2-hydroxy fatty acyl chain
recorded with the MALDI Q-TOF mass spectrometer.
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acid was substituted on galactose, as in the spectrum of
GD1a, only the mono-sialyl ion at m/z 314.1 was present
(data not shown).
Application to Glycosphingolipids from Mouse
Models of Glycolipid Storage Diseases
The GSL lysosomal storage diseases [31] are a group of
relatively rare genetic disorders in which the genes
encoding the catabolic enzymes for GSLs are mutated,
leading to accumulations of substrate. Deficiency of
-galactosidase A leads to accumulation of ceramide
trihexosides (globotriaosylceramide) in the liver, heart,
spleen, kidney, vascular endothelial cells, and plasma to
give a condition known as Fabry disease [32]. Figure 4
shows the MALDI Q-TOF spectra of ceramide trihexo-
side from the kidney (Figure 4a) and liver (Figure 4b) of
a mouse genetically altered to reproduce Fabry disease
[17]. The spectra showed a similar range of glycolipids
in both tissues (the abundant ion at m/z 1097.6 in the
sample from the liver (Figure 4b) was not a glycolipid
as shown by its MS/MS spectrum). The MS/MS spectra
confirmed the presence and sequence of the trihexose
moiety. An ion at m/z 264 in the spectra of all the major
compounds, confirmed the sphingosine as being d18:1
and the heterogeneity as being in the acyl group. Other
studies on the ceramide portion of murine glycolipids
have shown similar profiles [33] indicating that the
Fabry disease has not significantly affected the cer-
amide portion of the molecule.
Conclusions
Collisional cooling of the ion beam enabled both MS
and MS/MS spectra to be recorded with the Q-TOF
instrument from the MALDI ion source. GSLs produced
singly charged [M  Na] ions which reflected the
relative amounts of substance present in the sample and
gave spectra that were very similar to those recorded
with a reflectron-TOF instrument. Consequently,
MS/MS spectra could be recorded with the Q-TOF
instrument from the [M  Na] ions from all compo-
nents in mixtures. The more common electrospray ion
source failed to produce [MNa] ions from the larger
compounds. The effective decoupling of the ion pro-
duction from the ion analysis stages enabled MS/MS
spectra to be obtained that were independent of the
method of ion production and provided a means of
obtaining high quality fragmentation spectra from un-
derivatized GSLs.
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